Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (225)
|
Core Tip (239)
|
Full Article (HTML) (1201)
|
Full Article (PDF)-378K (82)
|
Full Article with Cover (PDF)-633K (46)
|
Full Article (XML)-71K (43)
|
Audio-3309K (12)
|
Peer-Review Report-245K (36)
|
Answering Reviewers-157K (37)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2237)
|
Similar Articles (140)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches

World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (253)
|
Core Tip (241)
|
Full Article (HTML) (3015)
|
Figures (1-1) (204)
|
Tables (1-3) (185)
|
Full Article (PDF)-4025K (241)
|
Full Article with Cover (PDF)-4275K (58)
|
Full Article (XML)-507K (36)
|
Audio-1047K (22)
|
Peer-Review Report-271K (30)
|
Answering Reviewers-120K (44)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4980)
|
Similar Articles (333)
|
Timeline of Article Publication (11)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (222)
|
Core Tip (251)
|
Full Article (HTML) (1347)
|
Figures (1-1) (184)
|
Full Article (PDF)-1122K (91)
|
Full Article with Cover (PDF)-1376K (57)
|
Full Article (XML)-113K (32)
|
Audio-412K (13)
|
Peer-Review Report-223K (43)
|
Answering Reviewers-109K (33)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3015)
|
Similar Articles (1750)
|
Timeline of Article Publication (7)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes

World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (224)
|
Core Tip (246)
|
Full Article (HTML) (1147)
|
Figures (1-1) (184)
|
Tables (1-6) (175)
|
Full Article (PDF)-876K (60)
|
Full Article with Cover (PDF)-1130K (33)
|
Full Article (XML)-191K (33)
|
Audio-454K (14)
|
Peer-Review Report-229K (35)
|
Answering Reviewers-124K (28)
|
Supplementary Material-657K (36)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2937)
|
Similar Articles (32)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms

World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (247)
|
Core Tip (256)
|
Full Article (HTML) (1097)
|
Figures (1-4) (191)
|
Tables (1-3) (208)
|
Full Article (PDF)-8140K (84)
|
Full Article with Cover (PDF)-8392K (50)
|
Full Article (XML)-121K (33)
|
Audio-885K (23)
|
Peer-Review Report-197K (41)
|
Answering Reviewers-155K (36)
|
Supplementary Material-123K (33)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3272)
|
Similar Articles (17)
|
Timeline of Article Publication (7)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (225)
|
Core Tip (235)
|
Full Article (HTML) (1024)
|
Figures (1-2) (221)
|
Tables (1-3) (203)
|
Full Article (PDF)-3168K (79)
|
Full Article with Cover (PDF)-3422K (46)
|
Full Article (XML)-97K (41)
|
Audio-586K (16)
|
Peer-Review Report-221K (50)
|
Answering Reviewers-311K (41)
|
Supplementary Material-128K (42)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (3082)
|
Similar Articles (3)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA

World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (219)
|
Core Tip (234)
|
Full Article (HTML) (851)
|
Figures (1-6) (196)
|
Full Article (PDF)-10367K (68)
|
Full Article with Cover (PDF)-10622K (69)
|
Full Article (XML)-108K (34)
|
Audio-200K (10)
|
Peer-Review Report-203K (43)
|
Answering Reviewers-316K (73)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2053)
|
Similar Articles (1171)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway

World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (213)
|
Core Tip (216)
|
Full Article (HTML) (1051)
|
Figures (1-8) (215)
|
Full Article (PDF)-42475K (80)
|
Full Article with Cover (PDF)-42729K (45)
|
Full Article (XML)-113K (30)
|
Audio-352K (12)
|
Peer-Review Report-309K (29)
|
Answering Reviewers-116K (33)
|
Supplementary Material-190K (30)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2294)
|
Similar Articles (138)
|
Timeline of Article Publication (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption

World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (202)
|
Core Tip (228)
|
Full Article (HTML) (1000)
|
Figures (1-6) (199)
|
Tables (1-1) (183)
|
Full Article (PDF)-10815K (76)
|
Full Article with Cover (PDF)-11065K (51)
|
Full Article (XML)-143K (36)
|
Audio-400K (12)
|
Peer-Review Report-253K (35)
|
Answering Reviewers-98K (38)
|
Supplementary Material-270K (44)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2925)
|
Similar Articles (18)
|
Timeline of Article Publication (2)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells

World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (223)
|
Core Tip (244)
|
Full Article (HTML) (963)
|
Figures (1-7) (193)
|
Full Article (PDF)-9623K (76)
|
Full Article with Cover (PDF)-9876K (44)
|
Full Article (XML)-121K (29)
|
Audio-824K (13)
|
Peer-Review Report-275K (32)
|
Answering Reviewers-363K (36)
|
Supplementary Material-48K (31)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2315)
|
Similar Articles (1732)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?

World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (242)
|
Core Tip (254)
|
Full Article (HTML) (581)
|
Figures (1-1) (196)
|
Tables (1-2) (204)
|
Full Article (PDF)-471K (50)
|
Full Article with Cover (PDF)-728K (31)
|
Full Article (XML)-61K (34)
|
Audio-512K (14)
|
Peer-Review Report-257K (26)
|
Answering Reviewers-156K (35)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1877)
|
Similar Articles (24)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (240)
|
Core Tip (260)
|
Full Article (HTML) (821)
|
Tables (1-1) (231)
|
Full Article (PDF)-370K (61)
|
Full Article with Cover (PDF)-625K (42)
|
Full Article (XML)-56K (34)
|
Audio-2970K (11)
|
Peer-Review Report-217K (34)
|
Answering Reviewers-149K (30)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1998)
|
Similar Articles (162)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (246)
|
Core Tip (242)
|
Full Article (HTML) (2147)
|
Figures (1-1) (202)
|
Full Article (PDF)-1500K (91)
|
Full Article with Cover (PDF)-1754K (46)
|
Full Article (XML)-97K (31)
|
Audio-476K (15)
|
Peer-Review Report-468K (32)
|
Answering Reviewers-1818K (40)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3399)
|
Similar Articles (235)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed

World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (238)
|
Core Tip (245)
|
Full Article (HTML) (771)
|
Figures (1-1) (191)
|
Tables (1-1) (198)
|
Full Article (PDF)-578K (59)
|
Full Article with Cover (PDF)-834K (89)
|
Full Article (XML)-91K (24)
|
Audio-833K (12)
|
Peer-Review Report-243K (25)
|
Answering Reviewers-100K (22)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2146)
|
Similar Articles (1732)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (232)
|
Core Tip (256)
|
Full Article (HTML) (1733)
|
Full Article (PDF)-406K (125)
|
Full Article with Cover (PDF)-661K (98)
|
Full Article (XML)-95K (33)
|
Audio-989K (14)
|
Peer-Review Report-215K (27)
|
Answering Reviewers-118K (39)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2862)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy

World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (219)
|
Core Tip (218)
|
Full Article (HTML) (649)
|
Tables (1-1) (200)
|
Full Article (PDF)-366K (58)
|
Full Article with Cover (PDF)-621K (83)
|
Full Article (XML)-45K (32)
|
Audio-1658K (15)
|
Peer-Review Report-175K (24)
|
Answering Reviewers-38K (31)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1881)
|
Similar Articles (1782)
|
Timeline of Article Publication (0)
|
Authors Evaluation (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open